Linkedin
SCIRENT: Advancing cardiovascular research for a healthier tomorrow
Get in touch

Advancing Biopharmaceuticals
and Medical Technologies
in Cardiovascular Medicine

COVID-19 Keeping up trial safety and progress

Learn more
Services

Accelerate Your Research in Cardiovascular Trials

is a full-service contract research organization (CRO) specialized in cardiovascular research. Our services cover the whole spectrum of development.

Learn more
References

We Share Your Enthusiasm for Finding Effective Therapies

works with biopharmaceutical and medical technology companies across all phases of development. Our deep expertise in cardiovascular medicine makes us a strong partner for your cardiovascular trials.

Learn more
About

Together We Find the Right Solution

Accessible and responsive leadership, dedicated staff, and a specialized site network – this is how we help study sponsors develop innovative therapies.

Learn more
References

Clients & Partners

BLOG

Discover the latest updates on cardiovascular research

Insights

Precision Medicine in Cardiovascular Disease

Author: Wilhelm Haverkamp Published on:
We are at an unusual moment in cardiovascular medicine. For the first time, the biological mechanisms underlying inherited cardiomyopathies and arrhythmia syndromes are not merely characterised but therapeutically addressable. Artificial intelligence is unlocking diagnostic information embedded in data that clinicians...
Insights

Germany Fast-Track Pathway for Early Clinical Development

Author: Rita Hertrampf Published on:
Germany has significantly improved the attractiveness of early clinical development through the Medical Research Act (Medizinforschungsgesetz, MFG) to expedite the approval of mononational clinical trials. Sponsors conducting innovative studies in Germany can benefit from accelerated regulatory processes, streamlined ethics review,...
Press release

Prof. Dr. Wilhelm Haverkamp Appointed Chief Medical Officer at SCIRENT

Author: Wiebke Lesch Published on:
Berlin, 16. April 2026. SCIRENT announced the appointment of Prof. Dr. Wilhelm Haverkamp as Chief Medical Officer (CMO), effective immediately. In this role, Prof. Haverkamp will further strengthen SCIRENT’s medical and scientific leadership and expand the company’s activities in drug...
View all

Thank you. Your data was submitted successfully.

We will get in touch shortly.

Book a meeting

Thank you for your application.

We will get in touch shortly.